Department of Medicine, Hollings Cancer Center, Medical University of South Carolina,Charleston, South Carolina, USA.
J Leukoc Biol. 2010 Jan;87(1):25-34. doi: 10.1189/jlb.0409251.
Macrophages are an important source of inflammatory cytokines generated during the innate immune response,but in the microenvironment of certain tumors,macrophages promote tumor progression through their preferential secretion of cytokines that support tumor cell growth and suppress antitumoral immune responses. KSHV is the causative agent of KS and lymphomas preferentially arising in immuno compromised patients, and specific cytokines, including IL-6 and IL-10, have been implicated in KSHV-associated cancer pathogenesis. However, the contribution of KSHV-infected macrophages to the cytokine milieu within KSHV-related tumors is unclear. We found that individual KSHV-encoded miRNA induce IL-6 and IL-10 secretion independently and additively by murine macrophages and human myelomonocytic cells. Bioinformatics analysis identified KSHV miRNA binding sites formiR-K12-3 and miR-K12-7 within the 3'UTR of the basic region/leucine zipper motif transcription factor C/EBPbeta, a known regulator of IL-6 and IL-10 transcriptional activation.Subsequent immunoblot analyses revealed that miR-K12-3 and miR-K12-7 preferentially reduce expression of C/EBPbeta p20 (LIP), an isoform of C/EBPbeta known to function as a negative transcription regulator. In addition,RNA interference specifically targeting LIP induced basal secretion of IL-6 and IL-10 by macrophages.Taken together, these data support a role for KSHV miRNA in the programming of macrophage cytokine responses in favor of KSHV-related tumor progression.
巨噬细胞是固有免疫反应中产生炎症细胞因子的重要来源,但在某些肿瘤的微环境中,巨噬细胞通过优先分泌支持肿瘤细胞生长和抑制抗肿瘤免疫反应的细胞因子来促进肿瘤进展。KSHV 是 KS 和淋巴瘤的病原体,这些疾病优先发生在免疫功能低下的患者中,特定的细胞因子,包括 IL-6 和 IL-10,已被牵连到 KSHV 相关癌症的发病机制中。然而,KSHV 感染的巨噬细胞对 KSHV 相关肿瘤内细胞因子环境的贡献尚不清楚。我们发现,单个 KSHV 编码的 miRNA 可独立地、累加地诱导鼠巨噬细胞和人髓样细胞分泌 IL-6 和 IL-10。生物信息学分析确定了 KSHV miRNA 在基本区域/亮氨酸拉链模体转录因子 C/EBPbeta 的 3'UTR 中 miR-K12-3 和 miR-K12-7 的结合位点,C/EBPbeta 是 IL-6 和 IL-10 转录激活的已知调节剂。随后的免疫印迹分析显示,miR-K12-3 和 miR-K12-7 优先降低 C/EBPbeta p20(LIP)的表达,LIP 是 C/EBPbeta 的一种异构体,已知作为负转录调节剂发挥作用。此外,针对 LIP 的 RNA 干扰特异性地诱导巨噬细胞基础分泌 IL-6 和 IL-10。综上所述,这些数据支持 KSHV miRNA 在编程巨噬细胞细胞因子反应以有利于 KSHV 相关肿瘤进展中的作用。